How oncRNA Technology Could Revolutionize Cancer Diagnostics
November 14, 2022
An interview with Pat Arensdorf, co-founder and chief executive officer of Exai Bio, a biotech company founded on the scientific discoveries of UCSF's biochemistry professor Hani Goodarzi, PhD.